Financial Ratios Lam Research Corporation

Stocks

LRCX

US5128073062

Semiconductor Equipment & Testing

Real-time Estimate Cboe BZX Other stock markets 18:05:53 15/07/2026 BST			5-day change	1st Jan Change
326.53 ^USD	-5.65%		-3.05%	+88.69%

02:41pm	UBS Raises Lam Research Price Target to $435 From $375, Maintains Buy Rating	MT
07-14	Lam Research Insider Sold Shares Worth $6,124,470, According to a Recent SEC Filing	MT

5fd4a100df4784221.cPQawogFKs4tzImtVTiulSvr8pIkpCcZD2Zf2ZnmEa0.AqF7prlWc6F4_MufH1eZpnGT3_lKx08tODJqocaCfPI6pXX78TxlhXuUzA

Published financial data: LAM RESEARCH CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2021	2022	2023	2024	2025
Revenues	14.63B	17.23B	17.43B	14.91B	18.44B
Total Revenues	14.63B	17.23B	17.43B	14.91B	18.44B
Cost of Goods Sold, Total	7.82B	9.36B	9.57B	7.81B	9.46B
Gross Profit	6.81B	7.87B	7.86B	7.1B	8.98B
Selling General & Admin Expenses, Total	830M	886M	833M	868M	982M
R&D Expenses	1.49B	1.6B	1.73B	1.9B	2.1B
Other Operating Expenses, Total	2.32B	2.49B	2.56B	2.77B	3.08B
Operating Income	4.48B	5.38B	5.3B	4.33B	5.9B
Interest Expense, Total	-209M	-185M	-186M	-185M	-178M
Interest And Investment Income	19.69M	15.21M	139M	252M	231M
Net Interest Expenses	-189M	-170M	-47.48M	66.7M	53.13M
Currency Exchange Gains (Loss)	-6.96M	-723K	-7.08M	-4.84M	-26.41M
Other Non Operating Income (Expenses)	84.65M	-18.44M	-11.09M	34.44M	30.44M
EBT, Excl. Unusual Items	4.37B	5.19B	5.23B	4.42B	5.96B
Restructuring Charges	-	-	-120M	-61.56M	-
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	4.37B	5.19B	5.11B	4.36B	5.96B
Income Tax Expense	462M	588M	598M	532M	600M
Earnings From Continuing Operations	3.91B	4.61B	4.51B	3.83B	5.36B
Net Income to Company	3.91B	4.61B	4.51B	3.83B	5.36B
Net Income - (IS)	3.91B	4.61B	4.51B	3.83B	5.36B
Net Income to Common Incl Extra Items	3.91B	4.61B	4.51B	3.83B	5.36B
Net Income to Common Excl. Extra Items	3.91B	4.61B	4.51B	3.83B	5.36B
Per Share Items
Net EPS - Basic	2.72	3.29	3.33	2.91	4.17
Basic EPS - Continuing Operations	2.72	3.29	3.33	2.91	4.17
Basic Weighted Average Shares Outstanding	1.44B	1.4B	1.35B	1.31B	1.29B
Net EPS - Diluted	2.69	3.28	3.32	2.9	4.15
Diluted EPS - Continuing Operations	2.69	3.28	3.32	2.9	4.15
Diluted Weighted Average Shares Outstanding	1.45B	1.41B	1.36B	1.32B	1.29B
Normalized Basic EPS	1.9	2.32	2.41	2.1	2.9
Normalized Diluted EPS	1.88	2.31	2.41	2.09	2.89
Dividend Per Share	0.52	0.6	0.69	0.8	0.92
Payout Ratio	18.6	17.7	20.13	26.62	21.45
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	4.79B	5.72B	5.64B	4.69B	6.29B
EBITA	4.55B	5.46B	5.35B	4.38B	5.9B
EBIT	4.48B	5.38B	5.3B	4.33B	5.9B
EBITDAR	5.06B	6.04B	5.94B	4.95B	6.46B
Effective Tax Rate - (Ratio)	10.58	11.32	11.71	12.21	10.07
Current Domestic Taxes	451M	641M	573M	586M	725M
Current Foreign Taxes	163M	204M	197M	144M	238M
Total Current Taxes	614M	845M	770M	730M	963M
Deferred Domestic Taxes	-148M	-246M	-139M	-201M	-360M
Deferred Foreign Taxes	-3.62M	-11.45M	-33.07M	4.02M	-2.91M
Total Deferred Taxes	-151M	-257M	-172M	-197M	-363M
Normalized Net Income	2.73B	3.25B	3.27B	2.76B	3.72B
Interest on Long-Term Debt	204M	180M	180M	181M	174M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	1.49B	1.6B	1.73B	1.9B	2.1B
Net Rental Expense, Total	271M	328M	303M	260M	177M
Imputed Operating Lease Interest Expense	80.99M	93.41M	86.42M	73.28M	50.21M
Imputed Operating Lease Depreciation	190M	235M	217M	187M	126M
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	220M	259M	287M	293M	343M
Total Stock-Based Compensation	220M	259M	287M	293M	343M

Fiscal Period: June	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	4.42B	3.52B	5.34B	5.85B	6.39B
Short Term Investments	1.31B	136M	37.64M	-	-
Total Cash And Short Term Investments	5.73B	3.66B	5.37B	5.85B	6.39B
Accounts Receivable, Total	3.03B	4.31B	2.82B	2.52B	3.38B
Total Receivables	3.03B	4.31B	2.82B	2.52B	3.38B
Inventory	2.69B	3.97B	4.82B	4.22B	4.31B
Prepaid Expenses	208M	347M	214M	298M	440M
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	11.65B	12.29B	13.23B	12.88B	14.52B
Gross Property Plant And Equipment	2.75B	3.31B	3.74B	4.32B	4.89B
Accumulated Depreciation	-1.27B	-1.44B	-1.64B	-1.86B	-2.17B
Net Property Plant And Equipment	1.48B	1.87B	2.1B	2.46B	2.72B
Long-term Investments	-	125M	118M	-	-
Goodwill	1.49B	1.52B	1.62B	1.63B	1.63B
Other Intangibles, Total	132M	102M	138M	139M	182M
Deferred Charges Long-Term	-	-	30.08M	-	-
Other Long-Term Assets, Total	1.14B	1.29B	1.54B	1.63B	2.3B
Total Assets	15.89B	17.2B	18.78B	18.74B	21.35B
Liabilities
Accounts Payable, Total	830M	1.01B	471M	614M	854M
Accrued Expenses, Total	553M	481M	481M	517M	618M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	-	421K	501M	750M
Current Portion of Leases	56.66M	61.49M	72.62M	67.94M	83.35M
Current Income Taxes Payable	348M	466M	461M	187M	541M
Unearned Revenue Current, Total	967M	1.57B	1.7B	1.42B	2.57B
Other Current Liabilities	773M	973M	1B	1.03B	1.16B
Total Current Liabilities	3.53B	4.56B	4.18B	4.34B	6.57B
Long-Term Debt	4.96B	4.96B	4.96B	4.47B	3.72B
Long-Term Leases	148M	201M	211M	236M	204M
Other Non Current Liabilities	1.23B	1.19B	1.21B	1.17B	992M
Total Liabilities	9.86B	10.92B	10.57B	10.21B	11.48B
Common Stock, Total	143K	137K	133K	130K	1.27M
Additional Paid In Capital	7.05B	7.41B	7.81B	8.23B	8.7B
Retained Earnings	14.68B	18.45B	22.03B	24.81B	28.99B
Treasury Stock	-15.65B	-19.48B	-21.53B	-24.37B	-27.76B
Comprehensive Income and Other	-64.13M	-110M	-101M	-130M	-62.42M
Total Common Equity	6.03B	6.28B	8.21B	8.54B	9.86B
Total Equity	6.03B	6.28B	8.21B	8.54B	9.86B
Total Liabilities And Equity	15.89B	17.2B	18.78B	18.74B	21.35B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.42B	1.37B	1.33B	1.3B	1.27B
ECS Total Common Shares Outstanding	1.43B	1.37B	1.33B	1.3B	1.27B
Book Value / Share	4.23	4.58	6.16	6.55	7.77
Tangible Book Value	4.4B	4.66B	6.45B	6.77B	8.05B
Tangible Book Value Per Share	3.09	3.4	4.84	5.2	6.35
Total Debt	5.17B	5.22B	5.25B	5.27B	4.76B
Net Debt	-564M	1.57B	-126M	-577M	-1.63B
Debt Equivalent of Unfunded Proj. Benefit Obligation	297M	280M	318M	386M	424M
Debt Equivalent Oper. Leases	2.16B	2.63B	2.43B	2.08B	1.41B
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.52B	2.4B	3.2B	2.92B	2.66B
Inventories - Work In Process, Total	392M	471M	326M	284M	283M
Inventories - Finished Goods, Total	778M	1.09B	1.29B	1.01B	1.36B
Land - (BS)	84.68M	84.73M	98.74M	164M	166M
Buildings, Total	841M	1.12B	1.29B	1.61B	1.91B
Machinery, Total	1.61B	1.84B	2.06B	2.22B	2.49B
Full Time Employees	14.1K	17.7K	17.2K	17.45K	19K
Accumulated Allowance for Doubtful Accounts (Supple)	5.26M	5.61M	5.34M	5.28M	6.5M
Order Backlog	-	-	-	-	-

Fiscal Period: June	2021	2022	2023	2024	2025
Net Income	3.91B	4.61B	4.51B	3.83B	5.36B
Depreciation & Amortization - CF	237M	256M	291M	303M	386M
Amortization of Goodwill and Intangible Assets - (CF)	70.6M	78M	51.5M	56.3M	-
Depreciation & Amortization, Total	307M	334M	342M	360M	386M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	220M	259M	287M	293M	343M
Tax Benefit from Stock Options	-	-	-	-	-
Other Operating Activities, Total	-169M	-302M	-120M	-189M	-356M
Change In Accounts Receivable	-929M	-1.29B	1.45B	303M	-859M
Change In Inventories	-793M	-1.35B	-962M	529M	-181M
Change In Accounts Payable	185M	168M	-522M	126M	212M
Change in Unearned Revenues	508M	605M	163M	-277M	1.15B
Change in Other Net Operating Assets	350M	70.34M	27.18M	-320M	122M
Cash from Operations	3.59B	3.1B	5.18B	4.65B	6.17B
Capital Expenditure	-349M	-546M	-502M	-397M	-759M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-	-120M	-	-
Investment in Marketable and Equity Securities, Total	465M	1.17B	98.13M	37.77M	-
Other Investing Activities, Total	-42.16M	-7.58M	-11.17M	-11.71M	51.09M
Cash from Investing	73.27M	612M	-535M	-371M	-708M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	64.43M	66.18M	97.04M	-
Total Debt Issued	-	64.43M	66.18M	97.04M	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-862M	-76.32M	-89.38M	-353M	-507M
Total Debt Repaid	-862M	-76.32M	-89.38M	-353M	-507M
Issuance of Common Stock	122M	114M	121M	136M	143M
Repurchase of Common Stock	-2.7B	-3.87B	-2.02B	-2.84B	-3.42B
Common Dividends Paid	-727M	-815M	-908M	-1.02B	-1.15B
Common & Preferred Stock Dividends Paid	-727M	-815M	-908M	-1.02B	-1.15B
Other Financing Activities, Total	-2.11M	45K	-3.55M	-13.54M	143K
Cash from Financing	-4.17B	-4.58B	-2.83B	-4B	-4.94B
Foreign Exchange Rate Adjustments	7.22M	-30.23M	128K	-22.37M	28.32M
Net Change in Cash	-498M	-897M	1.81B	263M	557M
Supplemental Items
Cash Interest Paid	204M	176M	175M	173M	172M
Cash Income Tax Paid (Refund)	519M	808M	810M	992M	973M
Levered Free Cash Flow	2.27B	1.62B	3.7B	3.36B	4.42B
Unlevered Free Cash Flow	2.4B	1.74B	3.82B	3.47B	4.53B
Change In Net Working Capital	582M	1.67B	-382M	-513M	-875M
Net Debt Issued / Repaid	-862M	-11.89M	-23.21M	-256M	-507M

Fiscal Period: June	2021	2022	2023	2024	2025
Profitability
Return on Assets	18.4	20.33	18.4	14.41	18.4
Return on Total Capital	25.07	29.64	26.52	19.83	25.95
Return On Equity %	69.8	74.85	62.27	45.71	58.24
Return on Common Equity	69.8	74.85	62.27	45.71	58.24
Margin Analysis
Gross Profit Margin %	46.53	45.69	45.07	47.61	48.7
SG&A Margin	5.67	5.14	4.78	5.82	5.32
EBITDA Margin %	32.74	33.18	32.35	31.43	34.1
EBITA Margin %	31.13	31.69	30.68	29.4	32.01
EBIT Margin %	30.64	31.24	30.38	29.02	32.01
Income From Continuing Operations Margin %	26.72	26.73	25.88	25.68	29.06
Net Income Margin %	26.72	26.73	25.88	25.68	29.06
Net Avail. For Common Margin %	26.72	26.73	25.88	25.68	29.06
Normalized Net Income Margin	18.68	18.84	18.75	18.54	20.2
Levered Free Cash Flow Margin	15.5	9.42	21.25	22.52	23.99
Unlevered Free Cash Flow Margin	16.39	10.09	21.91	23.3	24.59
Asset Turnover
Asset Turnover	0.96	1.04	0.97	0.79	0.92
Fixed Assets Turnover	10.74	10.28	8.77	6.53	7.12
Receivables Turnover (Average Receivables)	5.71	4.69	4.88	5.58	6.25
Inventory Turnover (Average Inventory)	3.41	2.81	2.18	1.73	2.22
Short Term Liquidity
Current Ratio	3.3	2.69	3.16	2.97	2.21
Quick Ratio	2.48	1.75	1.96	1.93	1.49
Operating Cash Flow to Current Liabilities	1.02	0.68	1.24	1.07	0.94
Days Sales Outstanding (Average Receivables)	63.75	77.55	74.53	66.49	58.22
Days Outstanding Inventory (Average Inventory)	106.8	129.48	166.96	214.6	164.09
Average Days Payable Outstanding	30.06	31.51	25.88	27.9	27.99
Cash Conversion Cycle (Average Days)	140.49	175.52	215.62	253.18	194.32
Long Term Solvency
Total Debt/Equity	85.7	83.22	63.93	61.73	48.23
Total Debt / Total Capital	46.15	45.42	39	38.17	32.54
LT Debt/Equity	84.76	82.24	63.04	55.06	39.79
Long-Term Debt / Total Capital	45.64	44.88	38.46	34.04	26.84
Total Liabilities / Total Assets	62.07	63.49	56.29	54.44	53.8
EBIT / Interest Expense	21.49	29.13	28.4	23.35	33.11
EBITDA / Interest Expense	24.26	32.71	31.86	26.7	36.27
(EBITDA - Capex) / Interest Expense	22.58	29.76	29.17	24.56	32.01
Total Debt / EBITDA	1.02	0.86	0.88	1.07	0.74
Net Debt / EBITDA	-0.11	0.26	-0.02	-0.12	-0.25
Total Debt / (EBITDA - Capex)	1.1	0.95	0.97	1.16	0.83
Net Debt / (EBITDA - Capex)	-0.12	0.28	-0.02	-0.13	-0.29
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	45.61	17.78	1.17	-14.48	23.68
Gross Profit, 1 Yr. Growth %	47.66	15.67	-0.21	-9.66	26.53
EBITDA, 1 Yr. Growth %	62.77	19.34	-1.36	-16.89	34.19
EBITA, 1 Yr. Growth %	66.15	19.93	-2.07	-18.05	36.42
EBIT, 1 Yr. Growth %	67.63	20.08	-1.61	-18.31	36.42
Earnings From Cont. Operations, 1 Yr. Growth %	73.57	17.83	-2.05	-15.14	39.98
Net Income, 1 Yr. Growth %	73.57	17.83	-2.05	-15.14	39.98
Normalized Net Income, 1 Yr. Growth %	69.74	18.81	0.7	-15.45	34.74
Diluted EPS Before Extra, 1 Yr. Growth %	78.15	21.75	1.4	-12.68	43.1
Accounts Receivable, 1 Yr. Growth %	44.32	42.54	-34.55	-10.77	34.09
Inventory, 1 Yr. Growth %	41.54	47.48	21.43	-12.42	2.14
Net Property, Plant and Equip., 1 Yr. Growth %	18.55	26.87	12.01	17.32	10.27
Total Assets, 1 Yr. Growth %	9.16	8.2	9.22	-0.2	13.87
Tangible Book Value, 1 Yr. Growth %	25.15	5.83	38.36	5.04	18.87
Common Equity, 1 Yr. Growth %	16.52	4.17	30.77	4.01	15.48
Cash From Operations, 1 Yr. Growth %	68.74	-13.61	67.08	-10.17	32.69
Capital Expenditures, 1 Yr. Growth %	71.77	56.41	-8.14	-20.91	91.39
Levered Free Cash Flow, 1 Yr. Growth %	64.97	-28.43	128.18	-8.41	31.74
Unlevered Free Cash Flow, 1 Yr. Growth %	61.43	-27.5	119.73	-8.17	30.55
Dividend Per Share, 1 Yr. Growth %	13.04	15.38	15	15.94	15
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	23.09	30.96	9.16	-6.98	2.85
Gross Profit, 2 Yr. CAGR %	24.96	30.69	7.44	-5.05	6.92
EBITDA, 2 Yr. CAGR %	31.39	39.37	8.5	-9.46	5.6
EBITA, 2 Yr. CAGR %	32.53	41.16	8.37	-10.41	5.57
EBIT, 2 Yr. CAGR %	34.85	41.87	8.69	-10.35	5.57
Earnings From Cont. Operations, 2 Yr. CAGR %	33.55	43.01	7.43	-8.83	8.99
Net Income, 2 Yr. CAGR %	33.55	43.01	7.43	-8.83	8.99
Normalized Net Income, 2 Yr. CAGR %	33.66	42.01	9.38	-7.72	6.74
Diluted EPS Before Extra, 2 Yr. CAGR %	40.13	47.27	11.11	-5.9	11.8
Accounts Receivable, 2 Yr. CAGR %	44.2	43.42	-3.41	-23.58	9.38
Inventory, 2 Yr. CAGR %	32.14	44.48	33.82	3.12	-5.42
Net Property, Plant and Equip., 2 Yr. CAGR %	18.1	22.64	19.21	14.63	13.74
Total Assets, 2 Yr. CAGR %	15.07	8.68	8.71	4.41	6.61
Tangible Book Value, 2 Yr. CAGR %	21.73	15.08	21	20.55	11.74
Common Equity, 2 Yr. CAGR %	13.56	10.17	16.71	16.62	9.6
Cash From Operations, 2 Yr. CAGR %	6.29	20.73	20.14	22.51	9.18
Capital Expenditures, 2 Yr. CAGR %	7.25	63.91	19.86	-14.77	23.03
Levered Free Cash Flow, 2 Yr. CAGR %	9.3	8.66	27.8	43.83	9.85
Unlevered Free Cash Flow, 2 Yr. CAGR %	10.29	8.18	26.21	41.35	9.49
Dividend Per Share, 2 Yr. CAGR %	8.71	14.21	15.19	15.47	15.47
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.71	21.29	20.16	0.63	2.29
Gross Profit, 3 Yr. CAGR %	9.63	21.78	19.45	1.4	4.48
EBITDA, 3 Yr. CAGR %	10.6	27.25	24.2	-0.73	3.23
EBITA, 3 Yr. CAGR %	10.5	28.19	24.96	-1.27	2.62
EBIT, 3 Yr. CAGR %	11.73	29.73	25.58	-1.18	3.12
Earnings From Cont. Operations, 3 Yr. CAGR %	17.97	28.09	26.06	-0.69	5.18
Net Income, 3 Yr. CAGR %	17.97	28.09	26.06	-0.69	5.18
Normalized Net Income, 3 Yr. CAGR %	11.02	28.52	26.64	0.39	4.69
Diluted EPS Before Extra, 3 Yr. CAGR %	26.88	33.71	30.05	2.54	8.21
Accounts Receivable, 3 Yr. CAGR %	11.61	43.64	10.42	-5.93	-7.83
Inventory, 3 Yr. CAGR %	12.75	37.07	36.35	16.19	2.79
Net Property, Plant and Equip., 3 Yr. CAGR %	17.85	20.96	18.99	18.58	13.16
Total Assets, 3 Yr. CAGR %	8.39	12.74	8.86	5.66	7.47
Tangible Book Value, 3 Yr. CAGR %	-2.13	16.18	22.37	15.43	19.99
Common Equity, 3 Yr. CAGR %	-2.5	10.34	16.65	12.32	16.24
Cash From Operations, 3 Yr. CAGR %	10.55	-0.81	34.54	9.04	25.82
Capital Expenditures, 3 Yr. CAGR %	8.48	21.63	35.14	4.35	11.61
Levered Free Cash Flow, 3 Yr. CAGR %	12.81	-5.09	39.15	13.98	39.68
Unlevered Free Cash Flow, 3 Yr. CAGR %	13.83	-4.11	37	13.14	37.65
Dividend Per Share, 3 Yr. CAGR %	26.81	10.89	14.47	15.44	15.31
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	19.97	16.54	9.49	9.08	12.91
Gross Profit, 5 Yr. CAGR %	21.04	16.92	8.75	10.24	14.27
EBITDA, 5 Yr. CAGR %	28.53	20.83	9.76	11.05	16.4
EBITA, 5 Yr. CAGR %	29.91	21.45	9.64	11.07	16.58
EBIT, 5 Yr. CAGR %	33.07	23	10.51	11.91	17.15
Earnings From Cont. Operations, 5 Yr. CAGR %	33.72	22.09	13.64	11.8	18.93
Net Income, 5 Yr. CAGR %	33.72	22.09	13.64	11.8	18.93
Normalized Net Income, 5 Yr. CAGR %	35.41	22.83	10.36	12.57	18.27
Diluted EPS Before Extra, 5 Yr. CAGR %	38.81	28.8	20.32	16.18	22.41
Accounts Receivable, 5 Yr. CAGR %	19.11	20.85	5.34	11.6	10
Inventory, 5 Yr. CAGR %	22.58	26.33	20.75	22.32	17.79
Net Property, Plant and Equip., 5 Yr. CAGR %	18.22	22.28	18.39	18.39	16.86
Total Assets, 5 Yr. CAGR %	5.32	7.24	8.52	9.33	7.95
Tangible Book Value, 5 Yr. CAGR %	2.24	-1.47	6.54	17.91	18
Common Equity, 5 Yr. CAGR %	0.45	-1.63	4.78	12.81	13.78
Cash From Operations, 5 Yr. CAGR %	21.59	8.84	14.29	7.93	23.76
Capital Expenditures, 5 Yr. CAGR %	14.77	28.24	12.9	5.5	30.16
Levered Free Cash Flow, 5 Yr. CAGR %	19.68	4.51	18.58	12.08	26.33
Unlevered Free Cash Flow, 5 Yr. CAGR %	20.67	5.19	18.63	11.99	25.01
Dividend Per Share, 5 Yr. CAGR %	34.08	29.46	22.03	12.7	14.87